Lamivudine 57237-0274-24

Package NDC

57237-0274-24

Manufacturer: Rising Pharma Holdings, Inc.
Dosage Form: Solution
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: November 21, 2016
Listing Expires: December 31, 2026
Application: ANDA077695

Need to source Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lamivudine	10 mg/mL

Drug Class

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Selected Package

57237-0274-24Selected

240 mL in 1 BOTTLE (57237-274-24)